| Business Type | Exporter, Supplier, Retailer |
| Application | Tablets Should Be Swallowed Whole & Not Chewed Or Crushed |
| Dosage | 100 Mg Orally Once Daily |
| Packaging Type | Box |
| Click to view more | |
Product Details
EACH FILM-COATED LUCILORLA TABLET CONTAINS:
Lorlatinib……………………100mg
INDICATION:
LuciLorla is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
DOSAGE AND USE:
Recommended dosage: 100 mg orally once daily.
Severe Renal Impairment: 75 mg orally once daily.
Tablets should be swallowed whole & not chewed or crushed.EACH FILM-COATED LUCILORLA TABLET CONTAINS:
Lorlatinib……………………100mg
INDICATION:
LuciLorla is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
DOSAGE AND USE:
Recommended dosage: 100 mg orally once daily.
Severe Renal Impairment: 75 mg orally once daily.
Tablets should be swallowed whole & not chewed or crushed.
* Currently we are not Accepting Orders for this Product.
